Ensysce Biosciences (ENSCW) Gains from Sales and Divestitures (2022 - 2023)
Ensysce Biosciences (ENSCW) reported Gains from Sales and Divestitures of $61001.0 for Q4 2023, up 45.7% year-over-year from $41867.0 in Q4 2022, and up 6403.3% quarter-over-quarter from $938.0 in Q3 2023.
Ensysce Biosciences (ENSCW) Gains from Sales and Divestitures (2022 - 2023) Analysis & Trends
Ensysce Biosciences (ENSCW) has 2 years of Gains from Sales and Divestitures data on file, last reported at $61001.0 in Q4 2023.
- Gains from Sales and Divestitures for Q4 2023 came in at $61001.0, up 45.7% year-over-year; the trailing twelve-month figure through Dec 2023 was $61001.0 (up 45.7% YoY), and the FY2023 annual result was $61001.0, up 45.7% from the prior year.
- Gains from Sales and Divestitures rose to $61001.0 in Q4 2023 per ENSCW's latest filing, from $938.0 in the prior quarter.
- Over five years, Gains from Sales and Divestitures peaked at $61001.0 in Q4 2023 and troughed at $312.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ensysce Biosciences | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 61,001.00 |
| Dec 31, 2023 | 61,001.00 |
| Sep 30, 2023 | 938.00 |
| Sep 30, 2023 | 938.00 |
| Jun 30, 2023 | 624.00 |
| Jun 30, 2023 | 624.00 |
| Mar 31, 2023 | 312.00 |
| Mar 31, 2023 | 312.00 |
| Dec 31, 2022 | 41,867.00 |
| Dec 31, 2022 | 41,867.00 |
| Sep 30, 2022 | 34,867.00 |
| Sep 30, 2022 | 34,867.00 |